These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 345982)

  • 1. Clinical trials with "nifurtimox" in African trypanosomiasis.
    Janssens PG; De Muynck A
    Ann Soc Belg Med Trop; 1977; 57(4-5):475-80. PubMed ID: 345982
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of nifurtimox in human African trypanosomiasis].
    Moens F; De Wilde M; Ngato K
    Ann Soc Belg Med Trop; 1984 Mar; 64(1):37-43. PubMed ID: 6732304
    [No Abstract]   [Full Text] [Related]  

  • 3. NECT trial: more than a small victory over sleeping sickness.
    Opigo J; Woodrow C
    Lancet; 2009 Jul; 374(9683):7-9. PubMed ID: 19559477
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized, controlled trial of treatments for second-stage sleeping sickness.
    Woodrow CJ; Abel PM; Krishna S
    J Infect Dis; 2007 Aug; 196(4):650-1. PubMed ID: 17624857
    [No Abstract]   [Full Text] [Related]  

  • 5. [Follow-up study of therapy of trypanosomiasis in Kimpangu (Republic of Zaire)].
    Ruppol JF; Burke J
    Ann Soc Belg Med Trop; 1977; 57(4-5):481-94. PubMed ID: 610623
    [No Abstract]   [Full Text] [Related]  

  • 6. Existing chemotherapy and its limitations.
    Gutteridge WE
    Br Med Bull; 1985 Apr; 41(2):162-8. PubMed ID: 3161577
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of Chagas' disease].
    Apt W
    Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
    [No Abstract]   [Full Text] [Related]  

  • 8. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
    Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
    Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go.
    Chappuis F
    Clin Infect Dis; 2007 Dec; 45(11):1443-5. PubMed ID: 17990226
    [No Abstract]   [Full Text] [Related]  

  • 10. [Agents for the treatment of African sleeping sickness. Those developed in the last century].
    Schlitzer M
    Pharm Unserer Zeit; 2009; 38(6):552-8. PubMed ID: 19862727
    [No Abstract]   [Full Text] [Related]  

  • 11. An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire.
    Pepin J; Milord F; Mpia B; Meurice F; Ethier L; DeGroof D; Bruneel H
    Trans R Soc Trop Med Hyg; 1989; 83(4):514-7. PubMed ID: 2694491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in parasitemia evaluated using the modified Strout method in patients with acute Chagas disease under treatment].
    Castro C; Emanuel A
    Rev Soc Bras Med Trop; 1988; 21(4):177-80. PubMed ID: 3152133
    [No Abstract]   [Full Text] [Related]  

  • 13. Killer coma: the evolving story of sleeping sickness treatment.
    Lancet; 2010 Jan; 375(9709):93. PubMed ID: 20109869
    [No Abstract]   [Full Text] [Related]  

  • 14. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
    Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P
    J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of CNS-trypanosomiasis: the combined use of the arsenicals and nitro-compounds.
    Jennings FW
    Trop Med Parasitol; 1991 Jun; 42(2):139-42. PubMed ID: 1896771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma cruzi: a novel chemical class (nitrobenzofurans) active against infections of mice (Mus musculus).
    Kinnamon KE; Poon BT; Hanson WL; Waits VB
    Exp Parasitol; 1998 Jun; 89(2):251-6. PubMed ID: 9635449
    [No Abstract]   [Full Text] [Related]  

  • 17. 5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies.
    Cabrera E; Murguiondo MG; Arias MG; Arredondo C; Pintos C; Aguirre G; Fernández M; Basmadjián Y; Rosa R; Pacheco JP; Raymondo S; Di Maio R; González M; Cerecetto H
    Eur J Med Chem; 2009 Oct; 44(10):3909-14. PubMed ID: 19446929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Longitudinal study of the persistence of the therapeutic action of nifurtimox and benznidazole in patients with chronic chagas infection].
    Schenone H; Rojas A; Alfaro E; Concha L; Aranda R
    Bol Chil Parasitol; 1981; 36(3-4):59-62. PubMed ID: 6812600
    [No Abstract]   [Full Text] [Related]  

  • 19. Nifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case series.
    Checchi F; Piola P; Ayikoru H; Thomas F; Legros D; Priotto G
    PLoS Negl Trop Dis; 2007 Nov; 1(2):e64. PubMed ID: 18060083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types.
    Andrade SG; Magalhães JB; Pontes AL
    Bull World Health Organ; 1985; 63(4):721-6. PubMed ID: 3936634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.